UltraSure Anti-Perspirant and Deodorant Recalled for Manufacturing Facility Contamination
DermaRite Industries is recalling UltraSure Anti-Perspirant & Deodorant (118 mL spray) due to manufacturing facility contamination affecting all lots nationwide with expiration dates through August 2027.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with documented CGMP deviation at the manufacturing facility and identified contamination of other products produced there. Classified as High severity as a risk-of-harm product, though no illnesses or injuries have been reported.
Plain-English summary
UltraSure Anti-Perspirant & Deodorant, 118 mL spray bottles manufactured by DermaRite Industries, LLC, is being recalled nationwide. The recall affects all lots distributed in the United States with expiration dates on or before August 2027, representing approximately 37,379 units.
The FDA issued this Class II recall following identification of a Current Good Manufacturing Practice (CGMP) deviation at the manufacturing facility. During the investigation, other products and lots produced at the same facility were found to be contaminated.
This recall notice does not specify what action consumers should take with existing product. Consumers who have purchased UltraSure Anti-Perspirant & Deodorant should consult their healthcare provider, contact DermaRite Industries, LLC (7777 West Side Avenue, North Bergen, NJ 07047), or visit the FDA's Drug Recalls page for guidance.
The recalled product
- Product
- UltraSure Anti-Perspirant & Deodorant, Aluminum Sesquichlorohydrate 15%, 118 mL (4 fl. oz.), DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-266-04
- Manufacturer
- DermaRite Industries, LLC
- Category
- Drug — Personal Care / OTC
- Hazard
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots on or before expiry date 08/2027
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27